[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"second-degree-atrioventricular-block-mbitz-type-ii\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:second-degree-atrioventricular-block-mbitz-type-ii":39},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":13,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":33,"leadSponsor":35,"locationsCount":38},"100552571",false,"NCT06474819","Left Septal or Deep Septal Pacing to Prevent Pacing-induced Cardiomyopathy","DEEP","Inclusion Criteria:\n\n* First implant of a single-chamber or dual chamber pacemaker due to persistent bradycardia associated with high degree atrio-ventricular (AV) block (complete AV block or second degree type II AV block), with second-degree type I AV block (symptomatic or associated with intra-hisian or infra-hisian block), or with atrial fibrillation with symptomatic slow ventricular rate (\\\u003C45lpm).\n* LVEF\\>50% at echocardiography performed maximum 7 days before pacemaker implant.\n* Informed consent signature.\n\nExclusion Criteria:\n\n* Life expectancy \\\u003C12 months\n* Severe cardiac valvular abnormality requiring intervention\n* Unstable Angina, Acute myocardial infarction, coronary revascularization, valvular surgery or valvular percutaneous intervention in the 90 days prior to pacemaker implant.\n* Inclusion in another trial which may influence the results of this study.","ALL","18 Years",{"count":18,"type":19},326,"ESTIMATED","INTERVENTIONAL",[22],"NA","Multicenter randomized controlled trial which will include patients with left ventricular ejection fraction \\>50% requiring a first implant of a cardiac pacemaker with expected high pacing percentages.\n\nPatients will be randomized 1:1 to right ventricular apical pacing vs left septal or deep septal pacing. The primary endpoint will be pacing-induced cardiomyopathy during the first year of follow-up.",[25,26],"Complete Heart Block","Second Degree Atrioventricular Block Möbitz Type II","RECRUITING","2024-07-12",{"date":30,"type":31},"2024-07-15","ACTUAL",{"date":28,"type":31},{"date":34,"type":19},"2027-01-12",{"name":36,"class":37},"Institut d'Investigació Biomèdica de Bellvitge","OTHER",6,""]